RXI Pharma Announces Expansion of Clinical Pipeline with Exclusive License for Second Phase 2 Clinical Compound
December 19, 2014 at 07:06 AM EST
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing ...